When to Stop Bosentan for Serious Side Effects
Bosentan, used for pulmonary arterial hypertension, requires immediate discontinuation for serious liver injury signals like elevated liver enzymes (ALT/AST >3x upper limit of normal, especially if bilirubin rises or symptoms appear). The prescribing label states to stop the drug right away and monitor liver function closely afterward.[1]
Liver Toxicity Monitoring and Stopping Rules
Check liver enzymes monthly during the first year, then every 3 months. Stop bosentan immediately if:
- ALT/AST >8x upper limit.
- ALT/AST >5x upper limit lasting >2 weeks.
- ALT/AST >3x upper limit with symptoms (nausea, fatigue, jaundice) or bilirubin >2x upper limit.
Restarting is not recommended; alternative therapies are advised.[1][2]
Handling Other Serious Risks Like Pulmonary Edema
Discontinue bosentan at the first sign of pulmonary edema or heart failure symptoms linked to fluid retention, as it signals potential pulmonary veno-occlusive disease. Seek urgent medical evaluation.[1]
Hematologic Side Effects and Timing
Stop immediately for severe anemia (hemoglobin <8 g/dL) or drops >15% from baseline. Monitor hemoglobin every 1-3 months; transfusion may be needed alongside discontinuation.[1]
Teratogenicity and Pregnancy Concerns
Bosentan causes birth defects, so it's contraindicated in pregnancy. Stop immediately upon confirmed or suspected pregnancy and use contraception strictly. No specific "how soon" timeline, but cessation is non-negotiable.[1][2]
What Happens After Stopping
Liver function often normalizes within weeks to months post-discontinuation. No rebound effects noted, but patients need alternative PAH treatments like sildenafil or prostacyclins. Report to FDA MedWatch for ongoing monitoring.[1]
[1]: Bosentan Prescribing Information (Tracleer)
[2]: Drugs.com - Bosentan Side Effects and Warnings